According to a new report published by Transparency Market Research “Cell CultureMarket (Consumables: Media, Sera, Reagents; and Instruments: Culture Systems, Incubators, Bioreactors, Pipetting Instruments, Roller Bottle Equipment, Biosafety Cabinets, Cryostorage Equipment, Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2022,”the global market for cell culture was valued at USD 6.1billion in 2013 and is expected to reach USD 11.3 billion in 2022, expanding at a CAGR of 7.1% from 2014 to 2022.
Browse the full Cell Culture Market Report: http://www.transparencymarketresearch.com/cell-culture-market.html
a large patient pool suffering from bacterial and viral infections, malignant and metabolic diseases as well as research and development projects for drug discovery that are currently underway. Technological advancementsdelivering better specificity and sensitivity of culture reaction consumables coupled with low cost and robustness of cell culture optimization protocols are some factors that would increase the demand for research using cell culture across the globe. Due to rise in demand for more cell lines by pharmaceutical and biotechnology companies, cell culture researchers have increased their efforts to focus on cost effectiveness of various cell culture applications.
In terms of regional analysis, the cellculture market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Rest of the World. In 2013, growing incidence of cancerand metabolic diseases thatnecessitates crucial diagnosis and therapies,increasing demand for animal component-free media and automated cell culture systems.In addition, large number of market players in the U.S. focus on R&D activities for the introduction of newer application areas such as mutagenesis, carcinogenesis, and large scale manufacturing of biological compounds including vaccines and therapeutic proteins. Moreover, improved awareness regarding latest healthcare technologies, higher purchasing power, and affordability is likely to boost the cell culture market in North America. Factors such as rising trend towards automation of cell culture systems, use of animal component-free media, and multiplexing of consistent output are the major drivers expected to spur the demand for cell culture technologies in Europe.
Browse the full Press Release of Cell Culture System Market: http://www.transparencymarketresearch.com/pressrelease/cell-culture-market.htm
Asia Pacific has been identified as the most attractive market due to the presence of large patient pool, improved health care infrastructure, and increase in demand for biopharmaceuticals. It accounted for a share of 18.2% of global marketin 2013 in terms of revenue. China and India are expected to be the most lucrative markets for cell culture productsdue to continuous rise in health care expenditure as a result of rapid economic development. Countries in Latin America and Rest of the World are evolving in terms of their manufacturing capacity and consumption of cell culture products, thereby offering significant growth opportunities for the international and local companies. However, most countries in the Middle East and Africa are still hampered by limited awareness about science and technology. It is expected that improved awareness and rise in disposable income of the people might bridge this gap and provide cell culture industry with added business, investments, and partnerships.
The key players contributing to the global cell culture market comprises Becton, Dickinson and Company, EMD Millipore, Corning Life Sciences B.V., GE Healthcare, PromoCell GmbH, Inc.,Lonza Group Ltd., Sigma Aldrich Co. LLC, Thermo Fisher Scientific, Inc., VWR International, LLC, and Wheaton Industries, Inc.Thermo Fisher Scientific heldthe largest share in2013 followed by BD Biosciences due to their wide geographic presence, exhaustive product portfolio, and acquisition of emerging companies.High product differentiation plays a major role in determining the market position of the players. Large numbers of small market players are entering the cell culture market, especially in emerging economies. Outsourcing of cell culture processes to cell culture companies in emerging markets has increased competition in the market.
The global cell culturemarket is segmented as follows:
Global Cell CultureConsumables Market Revenue,by Products(USD Million)
o Chemically-defined Media
o Classical Media
o Lysogeny Broth
o Protein-free Media
o Serum-free Media
o Specialty Media
o Fetal Bovine Serum
o Other Animals Sera
o Amino Acids
o Attachment Factors
o Growth Factors and Cytokines
o Protease Inhibitors
Global Cell Culture Instruments Market Revenue, by Products (USD Million)
o Culture Systems
o Pipetting Instruments
o Roller Bottle Equipment
o Biosafety Cabinets
o Cryostorage Equipment
Global Cell Culture Market Revenue, by Geography (USD Million)
o North America
o Rest of Europe
o Asia Pacific
o Rest of Asia Pacific
o Latin America (LATAM)
o Rest of Latin America
o Rest of the World (RoW)
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453